Tech Company Financing Transactions
Chiral Quest Funding Round
Chiral Quest, based in Monmouth Junction, secured $13 million from Kleiner Perkins Caufield & Byers and private investors.
Transaction Overview
Company Name
Announced On
1/14/2009
Transaction Type
Venture Equity
Amount
$13,000,000
Round
Series B
Investors
Proceeds Purpose
The capital will be used to help build Chiral Quest Corps' new pilot plant and process R&D center in the BioBay, located in China's Suzhou Industrial Park. It will also be used to expand its production capabilities and to further the company's strategy of using advanced catalytic technologies and green chemistry in developing products for chiral drug intermediates and Active Pharmaceutical Ingredients (API), serving both the developmental and generic pharmaceutical industries.
Company Information
Company Status
Private & Independent
Industry
Enterprise IT
Mailing Address
7 Deer Park Dr. C1
Monmouth Junction, NJ 08852
USA
Monmouth Junction, NJ 08852
USA
Phone
Website
Email Address
Not Recorded
Overview
Chiral Quest uses the most economic and environmental friendly methods to produce chiral pharmaceutical intermediates and APIs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Wu
VP - Bus. Development
Ian Lennon
VP - R & D
Wenge Li
Browse more venture capital transactions:
Prev: 1/14/2009: Boston-Power venture capital transaction
Next: 1/15/2009: ServiceChannel venture capital transaction
Share this article
Where The Data Comes From
We report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs